Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 16, 2023
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
[ Wed, Aug 16th 2023
] - WOPRAI
Tue, August 15, 2023
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI
Silvan Tuerkcan Reiterated (TSHA) at Buy and Held Target at $4 on, Aug 15th, 2023
Silvan Tuerkcan of JMP Securities, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Buy and Held Target at $4 on, Aug 15th, 2023.
Silvan has made no other calls on TSHA in the last 4 months.
There are 2 other peers that have a rating on TSHA. Out of the 2 peers that are also analyzing TSHA, 0 agree with Silvan's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Silvan
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $7 on, Monday, August 14th, 2023
- Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $13 on, Thursday, July 6th, 2023
